CPT code 89258 covers laboratory cryopreservation of one or more embryos during an in vitro fertilization (IVF) cycle. This code captures a common ART laboratory procedure that enables fertility preservation and staged embryo transfer strategies, making it central to IVF service billing nationwide. Its proper use affects claims processing, benefit determinations, and patient financial responsibility across public and commercial payers.

Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical role of embryo cryopreservation, typical sites where the service is performed, and the payer mix likely to encounter this code. The publication summarizes benchmark billing practices, common claim considerations, and coding context relevant to laboratory reproductive services.

This analysis provides clinicians, billing professionals, and policy stakeholders with operational clarity about CPT code 89258, highlighting where it fits in IVF care pathways and what to expect from major payers and Medicare in applying coverage and claims adjudication practices. Data not available in the input for specific reimbursement rates, payer policy details, and associated diagnosis or taxonomy mappings.